HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence and characteristics of symptomatic and asymptomatic tuboovarian masses in women with HIV: an ultrasonographic study.

Abstract
HIV-positive women with pelvic inflammatory disease have been reported to have an increased prevalence of tuboovarian masses (TOMs). The aim of this study was to assess the prevalence of asymptomatic ultrasonographic TOMs in women with HIV and to identify associated factors in order to formulate a selective ultrasonographic screening strategy. Two-hundred and four HIV outpatients underwent transvaginal ultrasonography. Eight (3.9%) had a diagnosis of TOM (5 were asymptomatic). Two profiles of patients at risk for TOM were identified who could be considered for selective screening strategies: the 'long-term infected' (age>35 years, diagnosis of HIV infection more than 5 years ago, HIV clinical category C, CD4 counts below 200/mm(3), >5 lifetime partners and on antiretroviral therapy) and the 'recently diagnosed with HIV' (African ethnicity, age 25-35, HIV diagnosis in the previous year, >5 lifetime partners, HIV clinical category C and not on antiretroviral therapy).
AuthorsR Napolitano, M Sansone, M Floridia, C Cappelli, G M Maruotti, A Agangi, A Capone, L L Mazzarelli, P Martinelli
JournalInternational journal of STD & AIDS (Int J STD AIDS) Vol. 21 Issue 7 Pg. 472-6 (Jul 2010) ISSN: 1758-1052 [Electronic] England
PMID20852196 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Child
  • Early Detection of Cancer (methods)
  • Fallopian Tube Neoplasms (epidemiology, pathology)
  • Female
  • HIV Infections (complications)
  • Humans
  • Middle Aged
  • Ovarian Neoplasms (epidemiology, pathology)
  • Prevalence
  • Ultrasonography (methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: